![(4R,4'R,5S,5'S)-2,2'-(1,3-二氢-2H-茚满-2-亚烷基)双[4,5-二氢-4,5-二苯基恶唑],98％ (4R,4'R,5S,5'S)-2,2'-(1,3-Dihydro-2H-inden-2-ylidene)bis[4,5-dihydro-4,5-diphenyloxazole], 98%](https://img.nicebiochem.com/20250502/89f20c8981610e19156414693f4e35e9bbcfb53340c3e8864505e2df67fc248b.png)
(4R,4'R,5S,5'S)-2,2'-(1,3-二氢-2H-茚满-2-亚烷基)双[4,5-二氢-4,5-二苯基恶唑],98％ (4R,4'R,5S,5'S)-2,2'-(1,3-Dihydro-2H-inden-2-ylidene)bis[4,5-dihydro-4,5-diphenyloxazole], 98%
-
(4R,4'R,5S,5'S)-2,2'-(1,3-二氢-2H-茚满-2-亚烷基)双[4,5-二氢-4,5-二苯基噁唑] (4R,4'R,5S,5'S)-2,2'-(2,3-Dihydro-1H-indene-2,2-diyl)bis(4,5-diphenyl-4,5-dihydrooxazole)
S56697-100mg | 100mg
-
(4R,4'R,5S,5'S)-2,2'-环丁烯二[4,5-二氢-4,5-二苯基恶唑],98％ (4R,4'R,5S,5'S)-2,2'-Cyclobutylidenebis[4,5-dihydro-4,5-diphenyloxazole], 98%
ZMR-07-1076 | 100mg
-
（4R，4''R，5S，5''S）-2,2''-环亚丙基二[4,5-二氢-4,5-二苯基恶唑] (4R,4''R,5S,5''S)-2,2''-Cyclopropylidenebis[4,5-dihydro-4,5-diphenyloxazole]
S56700-250mg | 250mg
-
（4R，4''R，5S，5''S）-2,2''-环亚丙基二[4,5-二氢-4,5-二苯基恶唑] (4R,4''R,5S,5''S)-2,2''-Cyclopropylidenebis[4,5-dihydro-4,5-diphenyloxazole]
S56700-1g | 1g
-
(4R,4'R)-2,2'-(1,3-二氢-2H-茚满-2-亚烷基)双[4,5-二氢-4-异丙基恶唑],98％,(99％ee) (4R,4'R)-2,2'-(1,3-Dihydro-2H-inden-2-ylidene)bis[4,5-dihydro-4-isopropyloxazole], 98%, (99% ee)
ZMR-07-1434 | 100mg
-
(4R,4'R)-2,2'-(1,3-二氢-2H-茚满-2-亚烷基)双[4,5-二氢-4-叔丁基恶唑],98％,(99％ee ) (4R,4'R)-2,2'-(1,3-Dihydro-2H-inden-2-ylidene)bis[4,5-dihydro-4-tert-butyloxazole], 98%, (99% ee)
ZMR-07-1082 | 100mg
-
(4R,4'R)-2,2'-(1,3-二氢-2H-茚满-2-亚烷基)双[4,5-二氢-4-苯基噁唑 (4R,4'R)-2,2'-(2,3-Dihydro-1H-indene-2,2-diyl)bis(4-phenyl-4,5-dihydrooxazole)
V82725-100mg | 100mg
中文名称：(4R,4'R,5S,5'S)-2,2'-(1,3-二氢-2H-茚满-2-亚烷基)双[4,5-二氢-4,5-二苯基恶唑],98％
英文名称：(4R,4'R,5S,5'S)-2,2'-(1,3-Dihydro-2H-inden-2-ylidene)bis[4,5-dihydro-4,5-diphenyloxazole], 98%
其他规格：25mg；分子式：C39H32N2O2；分子量：560.7；储存条件：Store at 2-8℃。
您正在浏览的产品：(4R,4'R,5S,5'S)-2,2'-(1,3-二氢-2H-茚满-2-亚烷基)双[4,5-二氢-4,5-二苯基恶唑],98％
手机版：(4R,4'R,5S,5'S)-2,2'-(1,3-二氢-2H-茚满-2-亚烷基)双[4,5-二氢-4,5-二苯基恶唑],98％
本公司销售的所有产品仅供实验科研使用，不用于人体及临床诊断。
2. 优化激发/发射波长参数
3. 测试样品荧光强度并绘制校准曲线
4. 基于曲线进行样品纯度计算
以上信息仅供参考，请以相应标准的原文为准！